Gene · 7408
Papers3,538
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,538
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The influence of nanotopography on cell behaviour through interactions with the extracellular matrix - A review. | Bioact Mater | 2022 | 35386337 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| Structure-based design of stabilized recombinant influenza neuraminidase tetramers. | Nat Commun | 2022 | 35383176 | PubTator, text mining | PubMed |
| Platelet transmission electron microscopy for the assessment of poor biological response to antiplatelet agent: pilot descriptive and prospective study - ELECTROSTROKE. | BMJ Open | 2022 | 35379612 | PubTator, text mining | PubMed |
| Antiplatelet Activity of Tetramethylpyrazine via Regulation of the P2Y12 Receptor Downstream Signaling Pathway. | Evid Based Complement Alternat Med | 2022 | 35378909 | PubTator, text mining | PubMed |
| The Actin Regulators Involved in the Function and Related Diseases of Lymphocytes. | Front Immunol | 2022 | 35371070 | PubTator, text mining | PubMed |
| Comprehensive analysis of the correlations of S100B with hypoxia response and immune infiltration in hepatocellular carcinoma. | PeerJ | 2022 | 35368338 | PubTator, text mining | PubMed |
| Mitochondria-actin cytoskeleton crosstalk in cell migration. | J Cell Physiol | 2022 | 35342955 | PubTator, text mining | PubMed |
| Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study. | Kidney360 | 2022 | 35342886 | PubTator, text mining | PubMed |
| Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches. | Int J Mol Sci | 2022 | 35328719 | PubTator, text mining | PubMed |
| The Potent Phytoestrogen 8-Prenylnaringenin: A Friend or a Foe? | Int J Mol Sci | 2022 | 35328588 | PubTator, text mining | PubMed |
| The Interplay between Cell-Extracellular Matrix Interaction and Mitochondria Dynamics in Cancer. | Cancers (Basel) | 2022 | 35326584 | PubTator, text mining | PubMed |
| Failure Analysis of TEVG's II: Late Failure and Entering the Regeneration Pathway. | Cells | 2022 | 35326390 | PubTator, text mining | PubMed |
| Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: A systematic review and meta-analysis. | PLoS One | 2022 | 35312704 | PubTator, text mining | PubMed |
| Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade. | J Trop Med | 2022 | 35309872 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis. | BMC Cardiovasc Disord | 2022 | 35300607 | PubTator, text mining | PubMed |
| Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets. | Haematologica | 2022 | 35295075 | PubTator, text mining | PubMed |
| Insulin-like growth factor 2 mRNA-binding protein 2-regulated alternative splicing of nuclear factor 1 C-type causes excessive granulosa cell proliferation in polycystic ovary syndrome. | Cell Prolif | 2022 | 35293050 | PubTator, text mining | PubMed |
| The expression of HOXC10 is correlated with tumor-infiltrating immune cells in basal-like breast cancer and serves as a prognostic biomarker. | Ann Transl Med | 2022 | 35282072 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7408/papers?page=31